Novo Nordisk A S Cash Flow Statement (2015-2016) | NVO

Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016
Operating Activities
Net Income 1,886.00M1,557.00M1,509.00M1,511.00M1,765.00M1,910.00M
Gains from Sales and Divestitures 2,600.00M
Cash from Operations 620.00M1,784.00M1,802.00M1,485.00M1,104.00M2,184.00M
Depreciation, Depletion & Amortization
Amortization 1,492.00M1,231.00M
Depreciation & Amortization (CF) 100.00M96.00M94.00M150.00M92.00M109.00M
Change in Working Capital
Change in Taxes 394.00M326.00M260.00M301.00M369.00M399.00M
Investing Activities
Capital Expenditures 115.00M151.00M186.00M322.00M161.00M254.00M
Additional items
Free Cash Flow 505.00M1,633.00M1,616.00M1,163.00M943.00M1,930.00M
Net Cash Flow 620.00M1,784.00M1,802.00M1,485.00M1,104.00M2,184.00M